A randomized trial of pegylated‐interferon‐α2a plus ribavirin with or without amantadine in the re‐treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

Summary Background  There is yet no established treatment for chronic hepatitis C patients non‐responder to standard interferon and ribavirin. Aim  To evaluate efficacy and safety of pegylated‐interferon‐α2a plus ribavirin with or without amantadine in such patients. Methods  161 non‐responders to s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alimentary pharmacology & therapeutics 2006-10, Vol.24 (7), p.1079-1086
Hauptverfasser:	CIANCIO, A., PICCIOTTO, A., GIORDANINO, C., SMEDILE, A., TABONE, M., MANCA, A., MARENCO, G., GARBAGNOLI, P., ANDREONI, M., CARITI, G., CALLERI, G., SARTORI, M., CUSUMANO, S., GRASSO, A., RIZZI, R., GALLO, M., BASSO, M., ANSELMO, M., PERCARIO, G., CICCONE, G., RIZZETTO, M., SARACCO, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Digestive system Gastroenterology. Liver. Pancreas. Abdomen Human viral diseases Infectious diseases Medical sciences Pharmacology. Drug treatments Viral diseases Viral hepatitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!